Journals / Türk Göğüs Kalp Damar Cerrahisi Dergisi / 2013 / Cilt: 21 - Sayı: 3

Brugada sendromu ve anestezi

Brugada syndrome and anesthesia

Pages
849–857
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this systematic review, we discussed the anesthesia techniques, and the effects and safety of anesthesia applied in this rarely seen heart disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Brugada syndrome is a genetic disease leading to sudden cardiac death, which is characterized by a spontaneous or induced ST-segment elevation with right bundle branch block in V1-3 leads in electrocardiography in those without any structural heart disease.
📊
Key Findings & Data:As there is a limited number of experiences on anesthetizing patients with Brugada syndrome, no consensus report for clinical practice has been available yet.
💡
Conclusion & Impact:In this systematic review, we discussed the anesthesia techniques, and the effects and safety of anesthesia applied in this rarely seen heart disease.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Brugada syndrome is a genetic disease leading to sudden cardiac death, which is characterized by a spontaneous or induced ST-segment elevation with right bundle branch block in V1-3 leads in electrocardiography in those without any structural heart disease. As there is a limited number of experiences on anesthetizing patients with Brugada syndrome, no consensus report for clinical practice has been available yet. In this systematic review, we discussed the anesthesia techniques, and the effects and safety of anesthesia applied in this rarely seen heart disease.

Özet

Brugada sendromu, yapısal kalp hastalığı bulunmayanlarda, elektrokardiyografide V1-3 derivasyonlarında sağ dal bloku ile spontan ya da indüklenmiş ST-segment elevasyonu ile karakterize, ani kardiyak ölüme yol açan genetik bir hastalıktır. Brugada sendromu bulunan hastalarda anestezi uygulamasına ilişkin sınırlı sayıda deneyim mevcut olduğu için, klinik uygulamaya yönelik henüz bir uzlaşı raporu bulunmamaktadır. Bu sistematik derlemede nadir görülen bu kalp hastalığında uygulanan anestezi teknikleri ve anesteziklerin etkileri ve güvenliliği irdelendi.

🔖

Cite This Article

ÖZTÜRK, S., ÖZTÜRK, İ. (2022). Brugada sendromu ve anestezi. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 21 - Sayı: 3, 849–857. https://ajindex.com/articles/624596

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6
  2. Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012;76:1563-71
  3. Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation 2003;108:3092-6
  4. Brugada P, Benito B, Brugada R, Brugada J. Brugada syndrome: update 2009. Hellenic J Cardiol 2009;50:352-72
  5. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8
  6. Wilde AA, Antzelevitch C, Borggrefe M, Brugada J, Brugada R, Brugada P, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514-9
  7. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70
  8. Nademanee K, Veerakul G, Nimmannit S, Chaowakul V, Bhuripanyo K, Likittanasombat K, et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600
  9. Antzelevitch C. Brugada syndrome. Pacing Clin Electrophysiol 2006;29:1130-59
  10. Wolpert C, Echternach C, Veltmann C, Antzelevitch C, Thomas GP, Spehl S, et al. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome. Heart Rhythm 2005;2:254-60
  11. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:857-64
  12. Joshi S, Raiszadeh F, Pierce W, Steinberg JS. Antiarrhythmic induced electrical storm in Brugada syndrome: a case report. Ann Noninvasive Electrocardiol 2007;12:274-8
  13. Takagi M, Doi A, Takeuchi K, Yoshikawa J. Pilsicanide- induced marked T wave alternans and ventricular fibrillation in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:837
  14. Tatlı E, Gül Ç, Sürücü H, Özçelik F. Brugada sendromunda tanı, klinik seyir ve tedavi yaklaşımı. Turkiye Klinikleri J Med Sci 2005;25:560